Epstein-barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: A phenomenon with distinctive clinicopathologic features

American Journal of Surgical Pathology

Volumn 31, Issue 9, 2007, Pages 1310-1322

  Balagué, Olga ^a   Martínez, Antonio ^a   Colomo, Luís ^a   Roselló, Ester ^b   Garcia, Adriana ^a   Martínez Bernal, Mónica ^c   Palacín, Antonio ^a   Fu, Kai ^d   Weisenburger, Dennis ^d   Colomer, Dolors ^a   Burke, Jerome S ^e   Warnke, Roger A ^f   Campo, Elías ^a,g  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c Hospital Central Mendoza   (Argentina)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e ALTA BATES SUMMIT MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOSPITAL CLÍNIC   (Spain)

Author keywords

Angioimmunoblastic T cell lymphoma; B cell clones; Epstein Barr virus; Peripheral T cell lymphoma; Plasmablastic lymphoma; Plasmacytoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN; PENTAMIDINE; PREDNISONE; RITUXIMAB; STEROID; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; PERIPHERAL T CELL LYMPHOMA; PLASMA CELL; SKIN LYMPHOMA; T LYMPHOCYTE; VIRUS INFECTION;

ADOLESCENT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONE CELLS; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; PLASMA CELLS;

EID: 34548248331     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3180339f18     Document Type: Article

References (55)

1. Abruzzo LV, Schmidt K, Weiss LM, et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood. 1993;82:241-246.
2. Abruzzo LV, Griffith LM, Nandedkar M, et al. Histologically discordant lymphomas with B-cell and T-cell components. Am J Clin Pathol. 1997;108:316-323.
3. Anagnostopoulos I, Hummel M, Finn T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 1992;80:1804-1812.
4. Arrowsmith ER, Macon WR, Kinney MC, et al. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma. 2003;44:241-249.
5. Barzilai A, Trau H, David M, et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol. 2006;155:379-386.
6. Brauninger A, Spieker T, Willenbrock K, et al. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med. 2001;194:927-940.
7. Cesarman E, Nador RG, Aozasa K, et al. Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol. 1996;149:53-57.
8. Colomo L, Lopez-Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood. 2003;101:78-84.
9. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747.
10. Daibata M, Bandobashi K, Kuroda M, et al. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo. J Virol. 2005;79:5875-5879.
11. Dippel E, Assaf C, Hummel M, et al. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol. 1999;188:146-154.
12. Dunphy CH, Galambos C, Polski JM, et al. Extranodal post-transplant plasmacytic hyperplasia with subsequent posttransplant plasmacytic malignancy: six-year interval case report and review of the literature. Arch Pathol Lab Med. 2002;126:351-356.
13. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406-1412.
14. Feller AC, Griesser H, Schilling CV, et al. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol. 1988;133:549-556.
15. Foss HD, Herbst H, Oelmann E, et al. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol. 1993;84:627-635.
16. Frizzera G, Kaneko Y, Sakurai M. Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions. Leukemia. 1989;3:1-5.
17. Geissinger E, Bonzheim I, Krenacs L, et al. Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies. J Mol Diagn. 2005;7:455-464.
18. Higgins JP, van de RM, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol. 2000;114:236-247.
19. Ho JW, Liang RH, Srivastava G. Differential cytokine expression in EBV positive peripheral T cell lymphomas. Mol Pathol. 1999;52:269-274.
20. Horikawa K, Takatsu K. Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology. 2006;118:497-508.
21. Hsu SM, Hsu PL. Autocrine and paracrine functions of cytokines in malignant lymphomas. Biomed Pharmacother. 1994;48:433-444.
22. Hsu SM, Waldron JA Jr, Fink L, et al. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Hum Pathol. 1993;24:126-131.
23. Hsu SM, Waldron JW Jr, Hsu PL, et al. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol. 1993;24:1040-1057.
24. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.
25. Kapelushnik J, Ariad S, Benharroch D, et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol. 2001;113:425-428.
26. Khan G, Coates PJ, Kangro HO, et al. Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J Clin Pathol. 1992;45:616-620.
27. Knecht H, Martius F, Bachmann E, et al. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia. 1995;9:458-465.
28. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999;12:200-217.
29. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552-565.
30. Lipford EH, Smith HR, Pittaluga S, et al. Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. J Clin Invest. 1987;79:637-642.
31. Lome-Maldonado C, Canioni D, Hermine O, et al. Angioimmunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL? Leukemia. 2002;16:2134-2141.
32. Lopez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol 1998;8:849-855.
33. Martinez A, Pittaluga S, Villamor N, et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol. 2004;28:849-858.
34. Matsue K, Itoh M, Tsukuda K, et al. Development of Epstein-Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Int J Hematol. 1998;67:319-329.
35. Musson R, Radstone CR, Horsman JM, et al. Peripheral T cell lymphoma: the sheffield lymphoma group experience (1977-2001). Int J Oncol. 2003;22:1363-1368.
36. Nathwani BN, Rappaport H, Moran EM, et al. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer. 1978;41:578-606.
37. Nelson BP, Nalesnik MA, Bahler DW, et al. Epstein-Barr virusnegative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000;24:375-385.
38. Pirker R, Schwarzmeier JD, Radaszkiewicz T, et al. B-immunoblastic lymphoma arising in angioimmunoblastic lymphadenopathy. Acta Haematol. 1986;75:105-109.
39. Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol. 1999;23:1233-1240.
40. Razzouk BI, Srinivas S, Sample CE, et al. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis. 1996;173:529-535.
41. Reinhold U, Abken H. CD4+ CD7- T cells: a separate subpopulation of memory T cells? J Clin Immunol. 1997;17:265-271.
42. Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 2002;13:140-149.
43. Smith JL, Hodges E, Quin CT, et al. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol. 2000;156:661-669.
44. Swerdlow SH. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol. 1997;14:2-7.
45. Swinnen LJ. Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas. Semin Oncol. 2000;27:402-408.
46. Tan BT, Warnke RA, Arber DA. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn. 2006;8:466-475.
47. Tobinai K, Ohtsu T, Hayashi M, et al. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. Leuk Res. 1991;15:837-846.
48. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
49. Vrsalovic MM, Korac P, Dominis M, et al. T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma. Hematol Oncol. 2004;22:169-177.
50. Weiss LM, Chen YY, Liu XF, et al. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol. 1991;139:1259-1265.
51. Weiss LM, Jaffe ES, Liu XF, et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 1992;79:1789-1795.
52. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
53. Xu Y, McKenna RW, Hoang MP, et al. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature. Am J Clin Pathol. 2002;118:848-854.
54. Yamamoto H, Miwa H, Kato Y, et al. Angioimmunoblastic T cell lymphoma with an unusual proliferation of Epstein-Barr virus-associated large B cells arising in a patient with progressive systemic sclerosis. Acta Haematol. 2005;114:108-112.
55. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002;117:368-379.